154 related articles for article (PubMed ID: 10383534)
1. Nocturnal gastric acid breakthrough on proton pump inhibitors.
Savarino V; Mela GS
Aliment Pharmacol Ther; 1999 Jul; 13(7):977-8. PubMed ID: 10383534
[No Abstract] [Full Text] [Related]
2. An evaluation of the clinical implications of acid breakthrough in patients on proton pump inhibitor therapy.
Nzeako UC; Murray JA
Aliment Pharmacol Ther; 2002 Jul; 16(7):1309-16. PubMed ID: 12144581
[TBL] [Abstract][Full Text] [Related]
3. Nocturnal acid breakthrough: pH, drugs and bugs.
Tutuian R; Katz PO; Castell DO
Eur J Gastroenterol Hepatol; 2004 May; 16(5):441-3. PubMed ID: 15097034
[TBL] [Abstract][Full Text] [Related]
4. Absence of nocturnal acid breakthrough in Helicobacter pylori-positive subjects treated with twice-daily omeprazole.
Martínek J; Pantoflícková D; Hucl T; Benes M; Dorta G; Lukás M; Spicák J
Eur J Gastroenterol Hepatol; 2004 May; 16(5):445-50. PubMed ID: 15097035
[TBL] [Abstract][Full Text] [Related]
5. Gastric acidity and acid breakthrough with twice-daily omeprazole or lansoprazole.
Katz PO; Hatlebakk JG; Castell DO
Aliment Pharmacol Ther; 2000 Jun; 14(6):709-14. PubMed ID: 10848653
[TBL] [Abstract][Full Text] [Related]
6. Gastro-oesophageal reflux associated with nocturnal gastric acid breakthrough on proton pump inhibitors.
Katz PO; Anderson C; Khoury R; Castell DO
Aliment Pharmacol Ther; 1998 Dec; 12(12):1231-4. PubMed ID: 9882031
[TBL] [Abstract][Full Text] [Related]
7. Nocturnal acid breakthrough: clinical significance and correlation with esophageal acid exposure.
Ours TM; Fackler WK; Richter JE; Vaezi MF
Am J Gastroenterol; 2003 Mar; 98(3):545-50. PubMed ID: 12650785
[TBL] [Abstract][Full Text] [Related]
8. Review of immediate-release omeprazole for the treatment of gastric acid-related disorders.
Castell D
Expert Opin Pharmacother; 2005 Nov; 6(14):2501-10. PubMed ID: 16259581
[TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori, acid, and omeprazole revisited: bacterial eradication and rebound hypersecretion.
Kuipers EJ; Klinkenberg-Knol EC
Gastroenterology; 1999 Feb; 116(2):479-83. PubMed ID: 9922329
[No Abstract] [Full Text] [Related]
10. Nocturnal acid breakthrough and esophageal acidification during treatment with dexlansoprazole as compared to omeprazole in patients with gastroesophageal reflux disease.
Ghoshal UC; Blaachandran A; Rai S; Misra A
Indian J Gastroenterol; 2022 Aug; 41(4):405-414. PubMed ID: 35771390
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori infection influences nocturnal gastric acid breakthrough.
Katsube T; Adachi K; Kawamura A; Amano K; Uchida Y; Watanabe M; Kinoshita Y
Aliment Pharmacol Ther; 2000 Aug; 14(8):1049-56. PubMed ID: 10930899
[TBL] [Abstract][Full Text] [Related]
12. Nocturnal acid breakthrough in perspective: let's not throw out the baby with the bath water.
Castell DO
Am J Gastroenterol; 2003 Mar; 98(3):517-8. PubMed ID: 12650778
[No Abstract] [Full Text] [Related]
13. Helicobacter pylori eradication increases nocturnal acid breakthrough.
van Herwaarden MA; Samsom M; Smout AJ
Aliment Pharmacol Ther; 2000 Jul; 14(7):961-2. PubMed ID: 10886054
[No Abstract] [Full Text] [Related]
14. [Effect of H2-blockers and proton pump inhibitors on intragastric acidity and intraesophageal pH in patients with gastroesophageal reflux disease].
Ivanov AN; Iakovenko EP; Iakovenko AV
Eksp Klin Gastroenterol; 2004; (4):16-20, 107. PubMed ID: 15568661
[TBL] [Abstract][Full Text] [Related]
15. Should Helicobacter pylori be eradicated before starting long-term proton pump inhibitors?
Rauws EA
Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):569-73. PubMed ID: 9513835
[TBL] [Abstract][Full Text] [Related]
16. [Proton pump inhibitors, a family of drugs in continuous expansion].
Pellicano R
Minerva Gastroenterol Dietol; 2000 Dec; 46(4):231-41. PubMed ID: 19320085
[No Abstract] [Full Text] [Related]
17. Gastric acid-dependent diseases: a twentieth-century revolution.
Sachs G; Shin JM; Munson K; Scott DR
Dig Dis Sci; 2014 Jul; 59(7):1358-69. PubMed ID: 24852882
[No Abstract] [Full Text] [Related]
18. The effects of omeprazole 20 and 40 mg twice daily on intragastric acidity in duodenal ulcer patients.
Savarino V; Mela GS; Zentilin P; Mele MR; Vigneri S; Mansi C; Celle G
Aliment Pharmacol Ther; 1996 Jun; 10(3):367-72. PubMed ID: 8791965
[TBL] [Abstract][Full Text] [Related]
19. [Cause and prevention of nocturnal gastric acid breakthrough].
Adachi K; Kinoshita Y
Nihon Rinsho; 2002 Feb; 60 Suppl 2():779-83. PubMed ID: 11979888
[No Abstract] [Full Text] [Related]
20. Review article: the clinical influence of Helicobacter pylori in effective acid suppression-implications for the treatment of gastro-oesophageal reflux disease.
Martínek J; Kuzela L; Spicák J; Vavrecka A
Aliment Pharmacol Ther; 2000 Aug; 14(8):979-90. PubMed ID: 10930891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
